A complete training that will help you learn the main techniques and therapies to care for cancer patients in a comprehensive and professional manner"

grand master enfermeria oncologica

Thanks to scientific and technological advances in recent years, there has been a significant increase in the possibilities for treating and curing children and adults with oncological diseases.   

The nursing professional is a key role in the care of the oncology patient. Its form of intervention makes it possible to provide comprehensive care to the patient with closer communication, intervening in overlapping areas and also interacting within the family environment.

Nursing care for oncology patients and their families is a great challenge,  to the development this disease can have in patients. Thus, the specific treatments required by these patients, their side effects and the affective needs they require make this specialty essential in the field of nursing.

In order to provide an effective solution to this demand for nursing professionals, at TECH we have designed this Advanced Master’s Degree in Oncology Nursing, a unique study opportunity for those who wish to acquire a theoretical and practical specialization in a single program and under the same degree title. In this way, our students will have the opportunity to learn about the most appropriate treatment and care for cancer patients and their families, through theoretical content provided in an online format. 

The combination of multimedia resources, real clinical cases and up-to-date contents will complete the training of the student, who will also acquire skills in communication, psychosocial approach and research, essential to provide quality care based on scientific research. 

The up-to-date contents of this Advanced Master’s Degree and its integrative approach will provide a complete vision of all aspects related to Oncology Nursing. The contents will provide a journey through the diverse needs of cancer patients, whose particularities require personalized attention. 

This Advanced Master’s Degree in Oncology Nursing aims to train the professional through a complete, global and practical learning to enable them to act safely in each and every one of the areas that the nursing professional will develop in this field. 

Update your knowledge through the Advanced Master’s Degree program in Oncology Nursing"

This Advanced Master’s Degree in Oncology Nursing contains the most complete and up-to-date scientific program on the market. The most important features include:

  • Development of more than 75 clinical cases presented by experts in Oncology Nursing
  • The graphic, schematic, and eminently practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional practice
  • The latest information on care and intervention in Oncology Nursing
  • Practical exercises where the self-evaluation process can be carried out to improve learning
  • Algorithm-based interactive learning system for decision-making in the situations that are presented to the student
  • With special emphasis on evidence-based Nursing and research methodologies in Oncology Nursing
  • All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
  • Content that is accessible from any fixed or portable device with an Internet connection

This training will give you a sense of confidence in your daily practice which will help you grow both personally and professionally”

The teaching staff includes professionals from the field of Oncology Nursing, who bring their experience to this training program, as well as renowned specialists from leading scientific societies. 

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive training program to train in real situations. 

The design of the program is based on Problem-Based Learning, by means of which the nursing professional must try to solve the different professional practice situations that arise throughout the program. For this purpose, the physician will be assisted by an innovative interactive video system created by renowned and experienced experts in the field of Oncology Nursing with extensive teaching experience.  

We have the best teaching methodology and a multitude of simulated cases that will help you train in real situations"

master enfermeria oncologica

Make the most of the opportunity to learn about the latest advances in Oncology Nursing and improve the care of your patients"


The structure of the contents has been designed by a team of professionals from the best hospitals and universities in the country, who are aware of the relevance of up-to-date training in order to intervene in the prevention, care and monitoring of ontological health in our patients and are committed to quality teaching through new educational technologies. 

magister enfermeria oncologica

This Advanced Master’s Degree in Oncology Nursing contains the most complete and up-to-date scientific program on the market” 

Module 1. Introduction to Oncology. Oncology Nursing 

1.1. Oncology and Oncology Nursing

1.1.1. Introduction to Oncology Nursing
1.1.2. Cancer Definition 
1.1.3. Essential Histological Concepts 

1.2. Etiopathogenesis and Biology of Cancer

1.2.1. Etiopathogenic Theories Viral Theory Oncogene Theory Suppressor Genes Theory Gene Theory Inflammatory Theory 

1.2.2. Biology of Cancer Concepts in Cell Biology Mechanisms of Malignant Transformation 

1.3. Carcinogenesis

1.3.1. Genetic Alterations Proto-Oncogenes Tumor Repair Genes DNA Repair Genes 

1.3.2. Epigenetic Alterations 
1.3.3. Carcinogenic Agents 

1.4. Classification and Nomenclature of Tumors

1.4.1. Benign Tumors 
1.4.2. Malignant tumours 

1.5. Tumor Progression Staging

1.5.1. Tumor Dissemination Routes 
1.5.2. Staging Depending on the Size Depending on the Level of Differentiation 

1.6. Risk factors

1.6.1. Genetic Factors 
1.6.2. Hormonal Factors 
1.6.3. Radiation 
1.6.4. Tobacco 
1.6.5. Alcohol 
1.6.6. Diet 
1.6.7. Drugs 
1.6.8. Physical Agents 
1.6.9. Chemical Agents 
1.6.10. Biological Agents 
1.6.11. Occupational Exposure 

1.7. Epidemiology of Cancer

1.7.1. Cancer Epidemiology Worldwide 
1.7.2. Cancer Epidemiology in Spain Incidence Prevalence Mortality Survival 

1.8. Cancer Prevention

1.8.1. Types of Prevention 
1.8.2. Primary prevention Intervention Against Smoking Intervention Against Alcohol Consumption Promotion of Healthy Diet 

1.8.3. Secondary prevention 
1.8.4. Tertiary prevention 
1.8.5. Quaternary Prevention 

1.9. Early Detection Programs

1.9.1. Colorectal Cancer Early Detection Program 
1.9.2. Breast Cancer Early Detection Program 
1.9.3. Cervical Cancer Early Detection Program 

1.10. Global Assessment of the Oncologic Patient

1.10.1. Tumor Markers 
1.10.2. Imaging Tests 
1.10.3. Neurological Assessment Scales Quality of Life Rating Scales Symptom Assessment Functional Assessment Quality of life Assessment 

Module 2. Types of Tumors 

2.1. Hematological Tumors

2.1.1. Lymphoma 
2.1.2. Leukemia 
2.1.3. Myeloproliferative Syndromes 
2.1.4. Myelodysplastic Syndromes 
2.1.5. Plasma Cell Tumors 

2.2. Osteomuscular Tumors

2.2.1. Osteosarcoma 
2.2.2. Chondrosarcoma 
2.2.3. Ewing Sarcoma 
2.2.4. Soft Tissue Sarcomas

2.3. Tumours of the Digestive System

2.3.1. Oesophageal Cancer  
2.3.2. Gastric Cancer
2.3.3. Colorectal Cancer
2.3.4. Carcinoma of the Anus
2.3.5. Other Intestinal Tumors
2.3.6. Hepatocellular Carcinoma
2.3.7. Cholangiocarcinoma
2.3.8. Gallbladder Carcinoma
2.3.9. Pancreatic Cancer

2.4. Nervous System Tumours

2.4.1. Astrocytoma
2.4.2. Oligodendroglioma  
2.4.3. Glioblastoma  
2.4.4. Meningioma  
2.4.5. Neurinoma  
2.4.6. Schwannoma  

2.5. Genitourinary Tumors

2.5.1. Renal Carcinoma  
2.5.2. Urothelial Carcinoma  
2.5.3. Vesical Carcinoma  
2.5.4. Prostate Carcinoma  
2.5.5. Endometrial Cancer  
2.5.6. Ovarian Cancer  
2.5.7. Cervical Cancer  
2.5.8. Vulvar Cancer  
2.5.9. Testicular Cancer  
2.5.10. Penile Cancer  

2.6. Endocrine Tumors

2.6.1. Thyroid and Parathyroid Cancer  
2.6.2. Adrenal Carcinoma  
2.6.3. Neuroendocrine Tumors  
2.6.4. Gastric Carcinoid Tumour  
2.6.5. Multiple Endocrine Neoplasia Syndromes  

2.7. Head and Neck Tumors

2.7.1. Pituitary Tumors  
2.7.2. Oral Cavity Cancer  
2.7.3. Oropharyngeal and Nasopharyngeal Cancer  
2.7.4. Paranasal Sinus Cancer  
2.7.5. Cancer of Salivary Glands  
2.7.6. Laryngeal Cancer  

2.8. Dermatological Tumors

2.8.1. Melanoma  
2.8.2. Basal Cell Carcinoma  
2.8.3. Squamous cell carcinoma  

2.9. Breast Cancer

2.9.1. Histological Subtypes  
2.9.2. Molecular Subtypes  

2.10. Thoracic Tumors

2.10.1. Lung Cancer  
2.10.2. Thymoma  
2.10.3. Pleural Mesothelioma  

Module 3. Oncological Treatments  

3.1. Types of Treatment

3.1.1. Neoadjuvant Therapy  
3.1.2. Adjuvant Treatment  
3.1.3. Palliative treatment  
3.1.4. Targeted Therapy  

3.2. Oncologic Surgery

3.2.1. Essential Concepts  
3.2.2. Preoperative Assessment  
3.2.3. Surgical Techniques in the Main Tumors  
3.2.4. Surgical Emergencies  

3.3. Chemotherapy Treatment

3.3.1. Chemotherapy Fundamentals  
3.3.2. Chemotherapy Types Alkylating Agents Platinum Compounds Alkaloids of Plant Origin Antimetabolites Topoisomerase Inhibitors Antitumor Antibiotics Other Agents  

3.3.3. Types of Response  

3.4. Side Effects of Chemotherapy

3.4.1. Digestive Toxicity  
3.4.2. Cutaneous Toxicity  
3.4.3. Hematological Toxicity  
3.4.4. Cardiovascular Toxicity  
3.4.5. Neurological Toxicity  
3.4.6. Other Side Effects  

3.5. Radiotherapy Treatment

3.5.1. Types of Radiotherapy
3.5.2. Indications  

3.6. Side Effects of Radiotherapy

3.6.1. Head and Neck Radiotherapy
3.6.2. Thoracic Radiotherapy
3.6.3. Abdominal and Pelvic Radiotherapy  

3.7. Interventional Radiology Techniques

3.7.1. Radiofrequency  
3.7.2. Chemoembolization  
3.7.3. Radioembolization  
3.7.4. Others  

3.8. Hormonal Treatment

3.8.1. Antiestrogens  
3.8.2. Progestogens  
3.8.3. Aromatase Inhibitors  
3.8.4. Estrogens  
3.8.5. Antiandrógenos  
3.8.6. Gonadotropin Releasing Hormone Agonists  

3.9. Biological Treatments

3.9.1. Monoclonal Antibodies  
3.9.2. Kinase Inhibitors  
3.9.3. mTOR Inhibitors  
3.9.4. Immunoregulatory Cytokines  

3.10. Transplants

3.10.1. Solid Organ Transplant  
3.10.2. Bone Marrow Transplant  
3.10.3. Peripheral Blood Transplant  
3.10.4. Umbilical Cord Transplant  

Module 4. Nursing Role in the Administration of Chemotherapy Treatment

4.1. Reception and Storage of Cytostatic Products

4.1.1. Reception  
4.1.2. Storage  

4.2. Cytostatic Product Validation

4.2.1. Pharmaceutical Validation  
4.2.2. Worksheet  
4.2.3. Label  
4.2.4. Stability and Compatibility  

4.3. Cytostatic Product Preparation

4.3.1. Work Area Biological Safety Cabinet Laboratory Isolators Work Area Standards Cleaning Standards Workplace Contamination Effusions Accidental Exposures  

4.4. Administration

4.4.1. Administrator Protection  
4.4.2. Environmental Protection  
4.4.3. Error Prevention  
4.4.4. Venous Accesses  
4.4.5. Administration Techniques  

4.5. Routes of Administration of Chemotherapy

4.5.1. Definition  
4.5.2. Oral Chemotherapy  
4.5.3. Peripheral Venous Catheters Selection Criteria Type of Material Insertion Sites Placement Techniques Nursing care  

4.5.4. Central Venous Catheter with Reservoir Selection Criteria Type of Material Insertion Sites Placement Techniques Nursing care  

4.5.5. Percutaneous Insertion of Central Venous Catheter Selection Criteria Type of Material Insertion Sites Placement Techniques Nursing care  

4.5.6. Peripherally Inserted Central Venous Catheter Selection Criteria Type of Material Insertion Sites Placement Techniques Nursing care  

4.5.7. Intraperitoneal Chemotherapy Selection Criteria Administration Technique Nursing Care  

4.6. Complications of Venous Access

4.6.1. Introduction  
4.6.2. Early Complications Infections Pneumothorax Catheter Bending Catheter Malposition and Extravasation Arrhythmias Migration or Dislocation of the Catheter Catheter Fracture and Embolism Catheter Occlusion or Obstruction  

4.6.3. Late Complications Catheter Fracture Thrombosis Skin Necrosis Around the Device  

4.7. Phlebitis Management

4.7.1. Definition  
4.7.2. Causes  
4.7.3. Signs and Symptoms  
4.7.4. Classification  
4.7.5. Risk Factors  
4.7.6. Preventing Phlebitis  
4.7.7. Nursing Care  

4.8. Extravasation Management

4.8.1. Definition  
4.8.2. Extravasation Related Factors  
4.8.3. Preventing Extravasation 
4.8.4. Cytostatic Classification according to Extravasation Effects  
4.8.5. Extravasation Manifestations by Cytostatic  
4.8.6. General Treatment  
4.8.7. Specific Treatment  
4.8.8. Surgical Treatment  
4.8.9. Nursing care  

4.9. Exposure Risks During Administration

4.9.1. Affected Personnel  
4.9.2. Penetration Routes  
4.9.3. Genetic Risks  

4.10. Treatment of Cytostatic Waste and Excreta

4.10.1. Treating Excreta Urine Feces Sweat Trace  

4.10.2. Cytostatic Waste Treatment Regulations Types of Waste Material Required Required Material Elimination  

Module 5. Clinical Manifestations and Emergencies in the Oncologic Patient

5.1. Introduction to Semiology in the Oncologic Patient

5.1.1. Nurse Assessment the Oncologic Patient  
5.1.2. NANDA-NOC-NIC Care Plan  

5.2. Respiratory Manifestations

5.2.1. Dyspnoea  
5.2.2. Cough  
5.2.3. Hiccup  
5.2.4. Hemoptysis
5.2.5. Neoplastic Pleural Effusion  

5.3. Digestive System Manifestations

5.3.1. Dry Mouth  
5.3.2. Nausea and Vomiting  
5.3.3. Constipation. Fecaloma  
5.3.4. Diarrhea  
5.3.5. Gastric Crush Syndrome  
5.3.6. Dysphagia  
5.3.7. Sialorrhea  
5.3.8. Intestinal Obstruction  
5.3.9. Neoplastic Ascites  

5.4. Urinary Manifestations  

5.4.1. Bladder Spasm  
5.4.2. Urinary Incontinence  
5.4.3. Vesical Tenesmus  
5.4.4. Dysuria  
5.4.5. Hematuria  

5.5. Psychological Manifestations

5.5.1. Acute Confusional Syndrome  
5.5.2. Anxiety  
5.5.3. Depression  
5.5.4. Insomnia  

5.6. Nervous System Manifestations

5.6.1. Seizures  
5.6.2. Spinal Cord Compression  
5.6.3. Intracranial Hypertension  
5.6.4. Muscle Spasms  
5.6.5. Metabolic Encephalopathy  

5.7. Hematologic and Circulatory Manifestations

5.7.1. Hemorrhage  
5.7.2. Anaemia  
5.7.3. Superior Vena Cava Syndrome  
5.7.4. Neoplastic Pericardial Effusion  

5.8. Miscellaneous: Systemic Symptoms and Constitutional Syndrome

5.8.1. Asthenia  
5.8.2. Anorexia. Cachexia  
5.8.3. Diaphoresis  
5.8.4. Neoplastic Lymphedema  
5.8.5. Tumor Ulcers  
5.8.6. Pruritus  
5.8.7. Neoplastic Fever  

5.9. Basis of Pain in Oncologic Patients

5.9.1. Anatomophysiology  
5.9.2. Etiology  
5.9.3. Subjective Assessment  
5.9.4. Objective Assessment  
5.9.5. Measuring Instrumentation  

5.10. Analgesic Treatment Importance

5.10.1. Analgesic Treatment Myths  
5.10.2. Analgesia Modalities  

Module 6. Nursing Approach to Nutrition and Post-Surgical Care of the Oncology Patient

6.1. Nutrition in Cancer Prevention

6.1.1. Dietary Carcinogenesis  
6.1.2. Food and Nutrients  
6.1.3. Risk Factors and Protective Elements  
6.1.4. Lifestyle  

6.2. General Principles of Malnutrition in Oncology Patients

6.2.1. Epidemiology of Malnutrition  
6.2.2. Pathophysiology  
6.2.3. Types of Malnutrition  
6.2.4. Causes of Malnutrition in Oncology Patients Tumor-Related Patient-Related Treatment-Related  

6.2.5. Clinical Manifestations of Malnutrition Tumor Cachexia Sarcopenia  

6.3. Assessment of Nutritional Status

6.3.1. Clinical Record and Subjective Nutritional Assessment  
6.3.2. Screening Tests Malnutrition Screening Tool Patient-Generated Subjective Global Assessment  

6.3.3. Anthropometric Measurements  
6.3.4. Biochemical Measurements  

6.4. Nutritional and Pharmacological Approach

6.4.1. General Recommendations  
6.4.2. Recommendations in Altered Intake Situations Anorexia Nausea and Vomiting Dysphagia Dysgeusia Oral Mucositis Xerostomia Dysphagia to Liquids and Solids  

6.4.3. Nutritional Supplements  
6.4.4. Pharmacotherapy  

6.5. Enteral Nutrition

6.5.1. Indications  
6.5.2. Access Routes  
6.5.3. Enteral Nutrition Formulas  
6.5.4. Complications  

6.6. Parenteral Nutrition

6.6.1. Indications  
6.6.2. Access Routes  
6.6.3. Types of Parenteral Nutrition  
6.6.4. Nutritional Requirements  
6.6.5. Complications  

6.7. End-Of-Life Nutrition

6.7.1. Nutritional Intervention  
6.7.2. Assisted Nutrition and Hydration  
6.7.3. Ethical, Cultural and Religious Aspects  

6.8. Post-Surgical Care After Thoracic Surgery

6.8.1. Pulmonary Rehabilitation  
6.8.2. Respiratory Physiotherapy  

6.9. Care of Ostomized Patients

6.9.1. General Concepts  
6.9.2. Ostomies Classification Digestive Ostomies Digestive Ostomy Types Hygiene and Care Diet Psychological Aspects Complications Urinary Ostomies Types of Urinary Ostomy Hygiene and Care Respiratory Ostomies Types of Respiratory Ostomy Hygiene and Care  

6.10. Post-Surgical Care After Breast Tumor Surgery

6.10.1. Breast Cancer Surgery Psychological Impact  

6.10.2. Lymphedema Classification Epidemiology Etiology Clinical Manifestations Diagnosis Nursing Care  

Module 7. Nursing Care in the Palliative and Terminal Patient

7.1. Principles and Organization of Palliative Care

7.1.1. Palliative Care Definition Palliative Care Objectives Principles of Palliative Care  

7.1.2. History of Palliative Care  
7.1.3. Quality of Life  

7.2. Legislation and Ethical Aspects Related to Palliative Care

7.2.1. State Legislation  
7.2.2. Rights and Duties of the Patients  
7.2.3. Quaternary Prevention  
7.2.4. Informed Consent  

7.3. Main Signs and Symptoms in the Terminally Ill Patient

7.3.1. Digestive Manifestations Anorexia Constipation Nausea and Vomiting Cachexia Dryness and Mouth Lesions  

7.3.2. Respiratory Manifestations Dyspnoea Cough Hiccup Antemortem Rales  

7.3.3. Neuropsychological Manifestations Tiredness and Fatigue Insomnia Depression Delirium  

7.3.4. Genitourinary Manifestations Urinary Retention  

7.3.5. Pain
7.3.6. Fever and Dysthermia  
7.3.7. Emergencies in the Terminally Ill Patient Massive Hemorrhage Seizures Acute Respiratory Depression  

7.4. Nursing Care

7.4.1. Virginia Henderson Needs Model Need 1: Breathing Need 2: Nutrition/ Hydration Need 3: Elimination Need 4: Mobilization Need 5: Rest/ Sleep Need 6: Get Dressed Need 7: Temperature Need 8: Hygiene/ Skin Need 9: Security/safety Need 10: Communication Need 11: Religion/ Beliefs Need 12: Development Need 13: Recreational/Leisure Activities Need 14: Learn/ Discover  

7.5. End of Life

7.5.1. Last Days  
7.5.2. Agony Agony Situation Characteristics Care of the Dying  

7.5.3. Spiritual Care  
7.5.4. Sedation Refractory Symptoms Sedation Types Drugs Used Ethical Considerations  

7.6. Palliative Care and Comprehensive Care of the Oncology Patient

7.6.1. Multidisciplinary Team Role  
7.6.2. Care Models  
7.6.3. Family Care Family Symptoms in the Care of the Terminally Ill Patient Psychosocial Care  

7.7. Palliative Home Care

7.7.1. Medical history  
7.7.2. Home Care Process  
7.7.3. Dying at Home  

7.8. Grief

7.8.1. Definition  
7.8.2. Stages of Grief  
7.8.3. Manifestations of Grief  
7.8.4. Types of Grief Uncomplicated Grief Pathological Grief Anticipatory Grief Non-Complicated or Prolonged Grief  

7.8.5. Grief Completion  
7.8.6. Nursing Interventions in Grief  
7.8.7. Grief Management  

7.9. Palliative Care Bioethics 

7.9.1. Bioethics  
7.9.2. Human Dignity  
7.9.3. Quality of Life  
7.9.4. Ethical and Bioethical Issues at the End of Life  

7.10. Nursing Care Process (NCP) at the End of Life

7.10.1. Comprehensive Nursing Assessment  
7.10.2. Need for NCP in Palliative Patients  
7.10.3. Nursing Diagnosis (NANDA)  
7.10.4. Nursing Outcomes (NOC)  
7.10.5. Nursing Interventions (NIC)  

Module 8. Communication and Psychosocial Approach to the Oncology Patient in Nursing

8.1. Communication in Oncology  

8.1.1. Communication Role in Oncology  
8.1.2. Somatic-Psychological Interaction  
8.1.3. Bioethical Support 
8.1.4. Counseling Knowledge Attitudes Relational Strategies  

8.2. Denial Management Adaptive and Maladaptive Denial

8.2.1. Causes of Denial  
8.2.2. Nursing Professional Objectives  
8.2.3. Denial Management Factors Involved Nursing Interventions  

8.3. Communicating Bad News

8.3.1. How to Deliver Bad News 
8.3.2. Nursing Professional Objectives  
8.3.3. Factors Involved  
8.3.4. Bad News Delivery Strategies  

8.4. Decision-Making

8.4.1. From Communication to Deliberation  
8.4.2. Difficulty in Decision-Making  
8.4.3. Nursing Professional Objectives  
8.4.4. Factors Involved  
8.4.5. Deliberative Process  
8.4.6. Criteria for Assessing Decision-Making Capacity  
8.4.7. Problems in Decision-Making Capacity  

8.5. Conspiracy of Silence

8.5.1. The Conspiracy of Silence  
8.5.2. Causes of The Conspiracy of Silence  
8.5.3. Factors Involved  
8.5.4. Nursing Approach  

8.6. Aggression Management

8.6.1. Oncologic Patient Aggressiveness  
8.6.2. Causes of Hostile Reactions  
8.6.3. Nursing Professional Objectives  
8.6.4. Factors Involved  
8.6.5. Aggressive Patient Management  

8.7. Therapeutic Effort Limitation

8.7.1. The Therapeutic Effort Limitation  
8.7.2. Need to Limit Therapeutic Effort  
8.7.3. Nursing Professional Objectives  
8.7.4. Factors Involved  
8.7.5. Approach and Intervention  

8.8. Family Claudication

8.8.1. Familiar Claudication Prevention  
8.8.2. Claudication Causes  
8.8.3. Nursing Professional Objectives  
8.8.4. Factors Involved  
8.8.5. Approach and Intervention With Regards To Family Claudication  

8.9. Prevention of Complicated Family Grief

8.9.1. Complicated Family Grief  
8.9.2. Causes of Problems in the Grieving Process Personal Factors Situational factors Interpersonal Factors  

8.9.3. Nursing Professional Objectives  
8.9.4. Factors Involved  
8.9.5. Approach During Illness At the Time of Death  

8.10. Advance Directives

8.10.1. Advance Planning of Health Care Decisions
8.10.2. Need for Advance Directives
8.10.3. Nursing Professional Objectives  
8.10.4. Factors Involved  
8.10.5. Approach  
8.10.6. Specific Considerations  

Module 9. Oncology Nursing in the Pediatric and Elderly Patient 

9.1. General Context of Pediatric Oncology

9.1.1. Epidemiology of Pediatric Cancer  
9.1.2. Most Frequent Tumors in Pediatric Age Leukemia Types Lymphoma Brain Tumors Wilms Tumor (Nephroblastoma) Neuroblastoma Rhabdomyosarcoma Bone Tumors  

9.2. Main Treatments in the Pediatric Patient

9.2.1. Surgery  
9.2.2. Chemotherapy
9.2.3. Radiotherapy  
9.2.4. Hematopoietic Progenitor Transplantation  
9.2.5. Side effects  

9.3. Child and Family Focused Care

9.3.1. Quality of Life  
9.3.2. Family Role  
9.3.3. Emotional Impact 
9.3.4. Nurse Assessment and Management  

9.4. Pediatric Patient Nutrition

9.4.1. General Aspects  
9.4.2. Malnutrition Consequences  
9.4.3. Assessment  
9.4.4. Nutritional Support  

9.5. Psychological Care in Pediatric Oncology Patients

9.5.1. Emotional Support During Diagnosis  
9.5.2. Emotional Support During Treatment  
9.5.3. Emotional Support after the End of Treatment  

9.6. Palliative Care for Pediatric Patients

9.6.1. Most Frequents Symptoms  
9.6.2. Symptom Control Pain Management  
9.6.3. Palliative Sedation  
9.6.4. Coping with Death  
9.6.5. Spirituality  
9.6.6. Grief  

9.7. General Context of Oncogeriatrics

9.7.1. Cancer Epidemiology in the Elderly Population  
9.7.2. Specific Characteristics of the Elderly Cancer Patient Physiological Aging Polypharmacy Associated Pathology  

9.8. Particularities of Oncologic Treatment in the Elderly Patient

9.8.1. Chemotherapy
9.8.2. Radiotherapy  
9.8.3. Surgery  
9.8.4. Hormone Therapy  

9.9. Comprehensive Assessment in Elderly Oncologic Patients

9.9.1. Geriatric Assessment Methodology  
9.9.2. Frailty Screening  

9.10. Oncologic Pain in the Elderly Patient

9.10.1. Features  
9.10.2. Evaluation  
9.10.3. Pharmacological and Non-Pharmacological Treatment  

Module 10. Oncology Nursing Research 

10.1. Research Bases in Health Sciences

10.1.1. The Scientific Method Structure   
10.1.2. Quantitative and Qualitative Research Designs  
10.1.3. Variables Definition Sampling  
10.1.4. Data Analysis  
10.1.5. Results Presentation  

10.2. Oncology Applied Research

10.2.1. Medical History  
10.2.2. Current Overview  

10.3. Oncology Research Areas

10.3.1. Surgical Oncology  
10.3.2. Radiotherapy Oncology  
10.3.3. Medical Oncology  

10.4. Oncology Translational Research

10.4.1. Basic and Clinical Research  
10.4.2. Translational Research as a Roadmap  

10.5. Nursing Oncology Research Areas

10.5.1. Nursing Care Research  
10.5.2. Research on Oncology Patient Problems  
10.5.3. Research in Activities Derived from Other Disciplines  
10.5.4. Resource Management and Leadership  

10.6. Challenges for the Future of Oncology Nursing Research

10.6.1. History of Nursing Research  
10.6.2. Nursing Research Difficulties  
10.6.3. Future Outlook  

10.7. Guidelines for Junior Researchers

10.7.1. Research Project Design  
10.7.2. Main Groups and Research Lines  
10.7.3. Resources for Junior Researchers  
10.7.4. Financing Means  

10.8. Evidence-Based Nursing

10.8.1. Evidence-Based Practices in Oncology  

10.9. Critical Reading of Scientific Literature

10.9.1. Basis of Critical Reading  
10.9.2. Models of Critical Reading  

10.10. Research: ICT and Apps Applied to Oncology

10.10.1. Use and Communication between Professionals  
10.10.2. Patient Outreach  

Module 11. Introduction to Pediatric Cancer and Main Treatments

11.1. Children and Cancer

11.1.1. Epidemiology of Pediatric Cancer
11.1.2. Pathophysiology of Pediatric Cancer Characteristics Shared by Tumor Cells
11.1.3. Aetiology of Pediatric Cancer
11.1.4. Fundamentals of the Hematopoietic System and Blood Cells
11.1.5. Types of Pediatric Cancer
11.1.6. Diagnostic and Follow-up Procedures in Pediatric Oncohematology
11.1.7. Treatment of Pediatric Cancer
11.1.8. Chemotherapy (I)
11.1.9. Chemotherapy (II)
11.1.10. Late On-Set Side Effects of Treatments in Pediatric Cancer Survivors

Module 12. Malignant Oncohematologic Pathology in Pediatrics

12.1. Leukemias and Myelodysplastic Syndromes in Pediatrics

12.1.1. B-cell Pediatric Acute Lymphoblastic Leukemia
12.1.2. Lymphomas in Pediatrics
12.1.3. CNS Tumors in Pediatrics and Miscellaneous Intracranial and Intraspinal Neoplasms in Pediatrics
12.1.4. Neuroblastomas and Other Peripheral Nerve Cell Tumors in Pediatrics
12.1.5. Retinoblastomas in Pediatrics
12.1.6. Renal Tumors in Pediatrics
12.1.7. Liver Tumors in Pediatrics
12.1.8. Bone Tumors in Pediatrics
12.1.9. Soft Tissue Sarcomas and Other Extraosseous Sarcomas in Pediatrics
12.1.10. Other Malignant and Unspecified Neoplasms in Pediatrics

Module 13. Nursing Care in Pediatric Oncohematology (I)

13.1. Patient Safety in Nursing Care in the Unit

13.1.1. Safety in the Pediatric Oncology Unit
13.1.2. Nursing Care at the Onset
13.1.3. Nursing Care for Performing Diagnostic Tests
13.1.4. Nursing Care Venous Catheters (I)
13.1.5. Nursing Care Venous Catheters (II) Subcutaneous Reservoir
13.1.6. Nursing Care in the Administration of Antineoplastic Drugs
13.1.7. Nursing Care in the Intravenous Administration of Antineoplastic Drugs
13.1.8. Nursing Care in the Administration of Supportive Care Drugs
13.1.9. Transfusion Support in Pediatric Oncohematology

Module 14. Nursing Care in Pediatric Oncohematology (II)

14.1. The Importance of Observation and Active Nursing Listening in Pediatric Oncohematology

14.1.1. The Importance of Nursing Assessments in Pediatric Oncohematology
14.1.2. Most Common Nursing Diagnoses in Pediatric Oncohematology
14.1.3. Nursing Care in Symptom Control in Pediatric Oncohematology
14.1.4. Pain Management and Care in Pediatric Oncohematology
14.1.5. Skin Care in Pediatric Oncohematology
14.1.6. Nutrition in Children and Adolescents with Cancer
14.1.7. When the Response to Treatment is Not Adequate
14.1.8. "Carefully Care" for the Child/Adolescent With Cancer and Their Family
14.1.9. Research in Pediatric Oncohematology Care

Module 15. Hematopoietic Progenitor Transplantation in Pediatrics

15.1. Introduction to Hematopoietic Progenitor Transplantation

15.1.1. Indications for Hematopoietic Progenitor Transplantation (HPT) in Pediatrics
15.1.2. From Donation to Infusion of Hematopoietic Progenitors
15.1.3. Nursing Care in HPT Conditioning
15.1.4. Nursing Care During HP Infusion
15.1.5. Nursing Care Phase of Medullary Aplasia
15.1.6. Medium-Term Post-HPT Nursing Care
15.1.7. Follow-Up HPT Nursing Consultation
15.1.8. New Therapies for Treating Complications After HPT

Module 16. Emergencies and Critical Patients in Pediatric Oncology

16.1. Introduction to Emergencies in Pediatric Patients With Oncohematologic Pathology

16.1.1. Hematologic Emergencies in Pediatric Oncohematology
16.1.2. Mechanical and Neurological Emergencies in Pediatric Oncohematology
16.1.3. Metabolic and Abdominal Emergencies in Pediatric Oncohematology
16.1.4. Other Emergencies Derived From Treatment
16.1.5. Emergencies in the Post-Hematopoietic Progenitor Transplantation Patient
16.1.6. Pediatric Patient with Oncohematologic Pathology Requiring Intensive Care
16.1.7. Nursing Care of Pediatric Patients With Oncohematologic Diseases and Their Family, Admitted to the PICU
16.1.8. Pediatric Intensive Care Unit (PICU). Humanization Projects

Module 17. Palliative Care and Last Days in Oncologic Pediatrics

17.1. Pediatric Palliative Care History, Concepts, Peculiarities and Universal Principles

17.1.1. Objectives and Stages of the Therapeutic Approach in Pediatric Palliative Care
17.1.2. Comprehensive Care for Children and Adolescents With Oncohematological Disease in a Palliative Care Situation and Their Family
17.1.3. Symptom Control in Pediatric Oncology Palliative Care
17.1.4. Total Pain Control in Pediatric Oncology Palliative Care
17.1.5. Ethical Aspects and Decision-Making in Pediatric Oncology Palliative Care
17.1.6. Terminal Phase and Last Days Situation in Pediatric Oncology
17.1.7. Palliative Sedation in Pediatric Oncology
17.1.8. Appropriate End of Life Dignity and Support
17.1.9. In First Person Testimonial

Module 18. Therapy: Clinical Trials and Immunotherapy in Pediatric Oncology

18.1. Clinical Trials in Pediatric Oncohematology. Concepts and Historical Bases

18.1.1. Why Clinical Trials are Necessary in Pediatric Oncology?
18.1.2. Designing a Clinical Trial
18.1.3. Preparing and Starting a Clinical Trial
18.1.4. Developing a Clinical Trial
18.1.5. Professors Involved in a Clinical Trial
18.1.6. The Role of Nursing Professionals in the Clinical Trials in Pediatric Oncology
18.1.7. The Map of Nursing Professionals Skills in the Clinical Trials in Pediatric Oncology
18.1.8. Current Situation of Clinical Trials in Pediatrics
18.1.9. Present and Future of Pediatric Oncology Personalized Medicine

Module 19. Multidisciplinary and E-Health Support in Pediatric Oncohematology

19.1. Psychological Support of the Child During the Process of Living With Cancer
19.2. Psychological Support of the Adolescent During the Process of Living With Cancer
19.3. Psychological Support Needs of Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation and Their Family
19.4. Educational Support for Children and Adolescents with Cancer
19.5. The Support of the Social Worker in Pediatric Oncology
19.6. Associations of Parents of Children With Cancer and Other Non-Profit Entities
19.7. Volunteering in Pediatric Oncohematology Units
19.8. Pediatric Cancer and Society
19.9. Use of Information and Communication Technologies (ICTs) in Children and Adolescents with Cancer
19.10. Use of Information and Communication Technologies (ICTs and E-Health) for the Parents of Children and Adolescents with Cancer
19.11. Nursing Professionals, ICTs and E-Health

Module 20. Fostering, Caring and Accompanying in Pediatric Oncology

20.1. Comprehensive View of the Care of Children and Adolescents with Cancer and Their Family
20.2. Theories and Models That Approach the Integral Vision of Nursing
20.3. The Facilitating Role of Nursing in Pediatric Oncology
20.4. The Profile of Emotional Skills of Nursing in Pediatric Oncology
20.5. Therapeutic Communication in Pediatric Oncology
20.6. The Influence of the Environment and Surroundings when Accompanying Children with Cancer
20.7. Accompaniment for the Family System in Pediatric Oncology
20.8. Psychomotor and Affective Development of Infants and Preschoolers with Cancer
20.9. Emotion, Storytelling, and Meaningful Playtime in School-Aged Children with Cancer
20.10. Emotion, Storytelling and Socialization in Adolescents with Cancer
20.11. First Person Experiences

posgrado enfermeria oncologica

A unique, key and decisive specialization to boost your professional development”